Last updated on October 2017

A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation


Brief description of study

To investigate the safety and pharmacokinetics of apixaban in children with congenital or acquired heart disease who have a need for anticoagulation.

Clinical Study Identifier: NCT02981472

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Site 0051

Local Institution
Phoenix, AZ United States
  Connect »

Jane Burns, Site 0014

University Of California San Diego
La Jolla, CA United States
  Connect »

Site 0010

Local Institution
Atlanta, GA United States
  Connect »

R. Mark Payne, Site 0008

Riley Hospital For Children
Indianapolis, IN United States
  Connect »

Christina Vanderpluym, Site 0009

Boston Childrens Hospital
Boston, MA United States
  Connect »

Regine White, Site 0013

University Of Michigan
Ann Arbor, MI United States
  Connect »

James Cnota, Site 0006

Cincinnati Childrens Hospital Medical Center
Cincinnati, OH United States
  Connect »

Andrew Glatz, Site 0007

Childrens Hospital Of Philadelphia
Philadelphia, PA United States
  Connect »

Andrew Atz, Site 0012

Medical University Of South Carolina
Charleston, SC United States
  Connect »

Asra Khan, Site 0011

Texas Children'S Hospital
Houston, TX United States
  Connect »

Lindsay May, Site 0005

Primary Children's Hospital
Salt Lake City, UT United States
  Connect »

Site 0038

Local Institution
Caba, Argentina
  Connect »

Site 0039

Local Institution
Westmead, Australia
  Connect »

Site 0030

Local Institution
Parkville, Australia
  Connect »

Christoph Male, Site 0001

Medical University Of Vienna
Vienna, Austria
  Connect »

Site 0043

Local Institution
Brasilia, Brazil
  Connect »

Site 0022

Local Institution
Curitiba, Brazil
  Connect »

Site 0024

Local Institution
Passo Fundo, Brazil
  Connect »

Site 0023

Local Institution
Porto Alegre, Brazil
  Connect »

Site 0020

Local Institution
Campinas, Brazil
  Connect »

Site 0045

Local Institution
Sao Paulo, Brazil
  Connect »

Site 0015

Local Institution
Toronto, ON Canada
  Connect »

Site 0031

Local Institution
HUS, Finland
  Connect »

Site 0035

Local Institution
Marseille, France
  Connect »

Site 0037

Local Institution
Montpellier, France
  Connect »

Site 0034

Local Institution
Paris, France
  Connect »

Site 0036

Local Institution
Pessac, France
  Connect »

Brigitte Stiller, Site 0002

Universitatsklinikum Freiburg Kinderklinik
Freiburg, Germany
  Connect »

Rainer Kozlik-Feldmann, Site 0004

Uni Hamburg-Eppendorf
Hamburg, Germany
  Connect »

Gunter Balling, Site 0003

Deutsches Herzzentrum Munchen Des Freistaates Bayern
Muenchen, Germany
  Connect »

Site 0047

Local Institution
Petach Tikva, Israel
  Connect »

Site 0046

Local Institution
Tel Hashomer, Israel
  Connect »

Marco Bonvicini, Site 0028

A.O. Policlinico S. Orsola Malpighi
Bologna, Italy
  Connect »

Site 0027

Local Institution
Milano, Italy
  Connect »

Antonio Amodeo, Site 0026

Ospedale Bambino Gesu'
Roma, Italy
  Connect »

Site 0016

Local Institution
Mexico City, Mexico
  Connect »

Sonia Lazcano Bautista, Site 0044

Morales Vargas Centro de Investigacion, S.C.
Leon, Mexico
  Connect »

Site 0040

Local Institution
Leicester, United Kingdom
  Connect »

Site 0042

Local Institution
Bristol, United Kingdom
  Connect »